Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

August 31, 2012

Conditions
Biliary Tract Disease
Interventions
DRUG

Gemcitabine+5FU+Leucovorin

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

Changhua Christian Hospital

OTHER

collaborator

China Medical University Hospital

OTHER

collaborator

Mackay Memorial Hospital

OTHER

collaborator

Chi Mei Medical Hospital

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

National Cheng-Kung University Hospital

OTHER

collaborator

National Taiwan University Hospital

OTHER

lead

National Health Research Institutes, Taiwan

OTHER

NCT00201305 - Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract | Biotech Hunter | Biotech Hunter